Validation of an Automated Latex Particle-Enhanced Immunoturbidimetric von Willebrand Factor Activity Assay.
Chen D, Tange JI, Meyers BJ, Pruthi RK, Nichols WL, Heit JA
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of storage and assay type on the diagnosis of VWD.
Summary of Findings
The coefficient of variance (CV) of VWF:Lx was less than 10% between plasma collected over 21 days and between 2 plasma specimens measured fresh and stored for up to 8 h at room temperature. The authors report occasional interference with VWF:Lx from specimens with severe hyperlipemia, hyperbilirubinemia, hemolysis, and more than 500,000 platelets/uL in previously frozen specimens. A high degree of correlation in VWF activity was found between VWF:Lx and VWF:RCo (R2=0.93, P<0.001). Both assays properly classified 357 of 368 normal individuals with 11 individual classified as having low VWF. Of 57 specimens from individuals with type 1 VWD, 46 and 48 specimens were properly assigned by VWF:RCo and VWF:Lx, respectively. Among the 35 plasma specimens collected from patients with type 2 (A/B or M) VWD, 3 and 4 were missclassified as normal using the VWF:Lx and VWF:RCo, respectively; however, 4 of these were grossly lipemic. There were 8 specimens that were not initially distinguished as being severe type 1 or type 2M VWD. Using flow cytometry, 6 of these were classified as type 2M of which 5 had VWF:Lx measurements that were less than 70% of actual VWF levels . VWF:Lx was 92% sensitive at detecting acquired VWF abnormality, while VWF:RCo was 83% sensitive.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
None (Fresh)Diagnoses
Other diagnosesNormalNot specifiedPlatforms
ProteinHematology/ auto analyzerProteinClinical chemistry/auto analyzerProteinImmunoturbidometric assayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HyperbilirubinemiaHyperlipemiaType 1 von Willebrand diseaseType 2 A/B von Willebrand diseaseType 2M von Willebrand diseaseBiospecimen Aliquots and Components Biospecimen components BilirubinHemolysisLipidsPlatelet rich plasmaBiospecimen Aliquots and Components Hemolysis AbsentPresentStorage Time at room temperature 0 h1 h2 h3 h4 h5 h6 h7 h8 hImmunoturbidometric assay Specific Technology platform Latex particle enhanced immunoturbidimetric assay for VWFVWF ristocetin cofactor activity assay